Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.870E-06 | 3.701E-03 | CA1, CA12, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 3.690E-19 | 8.035E-15 | CA1, CA12, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.746E-16 | 5.167E-12 | CA1, CA12, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.172E-15 | 1.576E-11 | CA1, CA12, CA5A, CA5B, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 8.735E-19 | 2.795E-17 | CA12; CA1; CA5B; CA5A; CA7; CA6; CA9 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.406E-04 | 3.849E-03 | CYP1A2; CYP2C19 |
hsa05134 | Legionellosis_Homo sapiens_hsa05134 | 8.693E-04 | 8.583E-03 | CASP7; CASP1 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.212E-03 | 8.583E-03 | CYP1A2; ALDH1A1 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.364E-03 | 8.583E-03 | CYP1A2; CYP2C19 |
hsa05133 | Pertussis_Homo sapiens_hsa05133 | 1.609E-03 | 8.583E-03 | CASP7; CASP1 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.920E-03 | 8.776E-03 | CYP1A2; CYP2C19 |
hsa04210 | Apoptosis_Homo sapiens_hsa04210 | 5.475E-03 | 1.947E-02 | CASP7; LMNA |
hsa05010 | Alzheimer's disease_Homo sapiens_hsa05010 | 7.791E-03 | 2.493E-02 | CASP7; HSD17B10 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 1.464E-02 | 4.258E-02 | CYP1A2; ALDH1A1; CYP2C19; HSD17B10 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.994E-03 | 1.598E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | CASP1 |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA1 |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | CASP1 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
L00-L99: Diseases of the skin and subcutaneous tissue | Fibrosis | L90.5 | CASP1 |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | CA1 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; CA1 |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | CA1; CA1 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |